Tselepis AD - Search Results

1

Effects of 12 months of treatment with disease-modifying anti-rheumatic drugs on low and high density lipoprotein subclass distribution in patients with early rheumatoid arthritis: a pilot study.

Filippatos TD, Derdemezis CS, Voulgari PV, Tsimihodimos V, Elisaf MS, Tselepis AD, Drosos AA. Filippatos TD, et al. Among authors: tselepis ad. Scand J Rheumatol. 2013;42(3):169-75. doi: 10.3109/03009742.2012.745013. Epub 2013 Jan 14. Scand J Rheumatol. 2013. PMID: 23311768

2

Lipid profile in patients with microvascular angina.

Tselepis AD, Elisaf M, Goudevenos J, Tselegaridis T, Bairaktari E, Siamopoulos KC, Sideris D. Tselepis AD, et al. Eur J Clin Invest. 1996 Dec;26(12):1150-5. doi: 10.1046/j.1365-2362.1996.520609.x. Eur J Clin Invest. 1996. PMID: 9013091

3

Lipid abnormalities in Greek patients with coronary artery disease.

Elisaf MS, Siamopoulos KC, Tselegarides TJ, Bairaktari ETh, Goudevenos JA, Tselepis AD, Tsolas OE, Sideris DA. Elisaf MS, et al. Among authors: tselepis ad. Int J Cardiol. 1997 Apr 18;59(2):177-84. doi: 10.1016/s0167-5273(96)02916-6. Int J Cardiol. 1997. PMID: 9158172

4

Increased activity of platelet-activating factor acetylhydrolase in low-density lipoprotein subfractions induces enhanced lysophosphatidylcholine production during oxidation in patients with heterozygous familial hypercholesterolaemia.

Karabina SA, Elisaf M, Bairaktari E, Tzallas C, Siamopoulos KC, Tselepis AD. Karabina SA, et al. Among authors: tselepis ad. Eur J Clin Invest. 1997 Jul;27(7):595-602. doi: 10.1046/j.1365-2362.1997.1570706.x. Eur J Clin Invest. 1997. PMID: 9263748

5

High density lipoprotein changes in patients with microvascular angina.

Elisaf MS, Karabina SA, Tselepis AD. Elisaf MS, et al. Among authors: tselepis ad. Cardiovasc Res. 1998 Nov;40(2):418. doi: 10.1016/s0008-6363(98)00234-x. Cardiovasc Res. 1998. PMID: 9893737 No abstract available.

6

Association of the inflammatory state in active juvenile rheumatoid arthritis with hypo-high-density lipoproteinemia and reduced lipoprotein-associated platelet-activating factor acetylhydrolase activity.

Tselepis AD, Elisaf M, Besis S, Karabina SA, Chapman MJ, Siamopoulou A. Tselepis AD, et al. Arthritis Rheum. 1999 Feb;42(2):373-83. doi: 10.1002/1529-0131(199902)42:2<373::AID-ANR21>3.0.CO;2-3. Arthritis Rheum. 1999. PMID: 10025933 Free article.

7

Selective imidazoline receptor agonists and lipid metabolism.

Elisaf M, Tselepis A, Siamopoulos K. Elisaf M, et al. Clin Chem Lab Med. 1999 Feb;37(2):165. doi: 10.1515/CCLM.1999.029. Clin Chem Lab Med. 1999. PMID: 10219506 No abstract available.

8

Lipoprotein (a) levels, apolipoprotein (a) phenotypes and thyroid autoimmunity.

Bairaktari ET, Tselepis AD, Millionis HJ, Elisaf MS. Bairaktari ET, et al. Among authors: tselepis ad. Eur J Endocrinol. 1999 May;140(5):474-6. doi: 10.1530/eje.0.1400474. Eur J Endocrinol. 1999. PMID: 10229916 Clinical Trial.

9

Apolipoprotein(a) phenotypes and lipoprotein(a) concentrations in patients with renal failure.

Milionis HJ, Elisaf MS, Tselepis A, Bairaktari E, Karabina SA, Siamopoulos KC. Milionis HJ, et al. Am J Kidney Dis. 1999 Jun;33(6):1100-6. doi: 10.1016/S0272-6386(99)70147-2. Am J Kidney Dis. 1999. PMID: 10352198

10

Homogeneous HDL-cholesterol assay versus ultracentrifugation/dextran sulfate-Mg2+ precipitation and dextran sulfate-Mg2+ precipitation in healthy population and in hemodialysis patients.

Bairaktari E, Elisaf M, Katsaraki A, Tsimihodimos V, Tselepis AD, Siamopoulos KC, Tsolas O. Bairaktari E, et al. Among authors: tselepis ad. Clin Biochem. 1999 Jul;32(5):339-46. doi: 10.1016/s0009-9120(99)00031-4. Clin Biochem. 1999. PMID: 10480448

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

274 results

Search Page